Read publication

This newsletter provides a selection of legal developments from across Europe affecting the healthcare and life sciences industries.

In this issue:

Guest Feature: USA
Implications of a Trump Administration for the Healthcare Sector

European Union

  • VAT on blood plasma supplies
  • The European Court of Justice reiterates that parallel importers of medical devices are not required to carry out a further assessment to certify the conformity of the information

Belgian Competition Authority raids several companies active in the sector of wholesale distribution of pharmaceutical and para-pharmaceuticals products to pharmacies


  • The Senate approves the provisions of the 2017 Budget Law on the purchase of biotech medicines
  • Drugs for compassionate use
  • The AIFA publishes the final budgets for the 2016 pharmaceutical and hospital expenditure
  • The Court of Cassation confirms the public nature of the Provincial Health Authorities (ASP)

Kingdom of Saudi Arabia

  • Highlights
  • New regulations and consultations


  • Turkey Revises Guidelines for Users and Sellers of Cosmetic Products
  • TÄ°TCK Announces Procedure for Registration of Cosmetics Companies, Notification of Cosmetic Products and Export Certificates
  • Turkey Introduces Strict Requirements on Personal Health Data Processing

The Long-Awaited New Licensing Conditions on Turnover of Pharmaceuticals Become Effective

United Arab Emirates
Scientific offices: New Ministerial Decree

United Kingdom

  • Accelerated Access Review publishes Final Report into innovative medicines and medical technologies
  • Unified Patent Court: UK Government to continue preparations to ratify agreement
Explore More Insight